Eswatini vs Singapore: New or unknown treatment history cases: Pulmonary, bacteriologically
Eswatini
1,055
in 2023
Singapore
1,032
in 2023
Eswatini rank
108th
Singapore rank
109th
New or unknown treatment history cases: Pulmonary, bacteriologically over time
- Eswatini
- Singapore
How they compare
Eswatini currently reports 1,055 against 1,032 in Singapore, a difference of 23.
The two have swapped places 2 times across 11 shared years of data; in 2013 it was Eswatini ahead.
Eswatini ranks 108th and Singapore ranks 109th of 197 countries.
Eswatini has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Eswatini | Singapore | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 2,138 | 1,116 | 1,023 | Eswatini |
| 2020s | 1,066 | 1,058 | 8 | Eswatini |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher new or unknown treatment history cases: pulmonary, bacteriologically, Eswatini or Singapore?
- Eswatini, at 1,055 against 1,032 in Singapore as of 2023.
- What is the difference in new or unknown treatment history cases: pulmonary, bacteriologically between Eswatini and Singapore?
- 23, with Eswatini ahead.
- How many years of comparable data are there for Eswatini and Singapore?
- 11 years are reported by both, from 2013 to 2023.
- How do Eswatini and Singapore rank globally for new or unknown treatment history cases: pulmonary, bacteriologically?
- Eswatini ranks 108th and Singapore ranks 109th of 197 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as New or unknown treatment history cases: Pulmonary, bacteriologically confirmed. Statizoid refreshes it automatically from the source and publishes the full history for both places.